Redmile Group, LLC - Insider Trading & Ownership
-
Entity
-
Company
-
Location
-
One Letterman Drive, Building D, Suite D3 300, San Francisco, California
-
Summary
-
The estimated value of insider holdings of Redmile Group, LLC is at least $630 M dollars as of July 3, 2024. Redmile Group, LLC is the 10%+ Owner of ADC Therapeutics SA and owns shares of ADC Therapeutics SA (ADCT) stock worth about $150 M. Redmile Group, LLC is the 10%+ Owner of RayzeBio, Inc. and owns shares of RayzeBio, Inc. (RYZB) stock worth about $116 M. Redmile Group, LLC is the Director, 10%+ Owner of FATE THERAPEUTICS INC and owns shares of FATE THERAPEUTICS INC (FATE) stock worth about $79.1 M. Redmile Group, LLC is the Director, 10%+ Owner of IGM Biosciences, Inc. and owns shares of IGM Biosciences, Inc. (IGMS) stock worth about $70.8 M. Redmile Group, LLC is the Director, 10%+ Owner of Shattuck Labs, Inc. and owns shares of Shattuck Labs, Inc. (STTK) stock worth about $59.1 M. Redmile Group, LLC is the Director of Absci Corp and owns shares of Absci Corp (ABSI) stock worth about $41.1 M. Redmile Group, LLC is the 10%+ Owner of Entrada Therapeutics, Inc. and owns shares of Entrada Therapeutics, Inc. (TRDA) stock worth about $31.3 M. Redmile Group, LLC is the 10%+ Owner of Zymeworks Inc. and owns shares of Zymeworks Inc. (ZYME) stock worth about $30.6 M. Redmile Group, LLC is the Director, 10%+ Owner of Augmedix, Inc. and owns shares of Augmedix, Inc. (AUGX) stock worth about $19.5 M. Redmile Group, LLC is the 10%+ Owner of Verve Therapeutics, Inc. and owns shares of Verve Therapeutics, Inc. (VERV) stock worth about $19.4 M. Redmile Group, LLC is the 10%+ Owner of Adagio Therapeutics, Inc. and owns shares of Invivyd, Inc. (IVVD) stock worth about $13.4 M.